Adtech Pharma, founded in 2021 and based in Warwick, Rhode Island, is a biotech firm focused on developing innovative treatments for glaucoma. The company has created a novel formulation of a synthetic cannabinoid therapeutic specifically targeting this eye condition. Adtech's mission is to address unmet medical needs through scientific innovation while also building shareholder value. The company leverages a capital-efficient strategy and possesses a platform technology that could be applied to additional medical indications.
Adtech Pharma boasts a team of seasoned principals with extensive expertise in pharmaceutical development and successful drug launches. The company's unique therapeutic approach features a novel mechanism of action, supported by patent protection and scientifically proven efficacy and safety. This high-value asset aims to provide effective treatment options for patients who do not respond to current therapies, positioning Adtech as a significant player in the biotech industry.